Search research articles
Contact Us
Filters
Showing results (1-10 of 78) with videos related to
Page
of 8
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 26, 2013
Glutamate carboxypeptidase II is not an amyloid peptide-degrading enzyme
Jesse Alt, Marigo Stathis, Camilo Rojas, et al.
Analytical Biochemistry
|
January 14, 2015
Bioanalysis of 6-diazo-5-oxo-l-norleucine in plasma and brain by ultra-performance liquid chromatography mass spectrometry
Jesse Alt, Michelle C Potter, Camilo Rojas, et al.
Journal of Alzheimer'S Disease : JAD
|
March 19, 2019
The NAAG'ing Concerns of Modeling Human Alzheimer's Disease in Mice
Kristen R Hollinger, Jesse Alt, Rana Rais, et al.
ACS Medicinal Chemistry Letters
|
November 20, 2014
Structure-Metabolism Relationships in the Glucuronidation of d-Amino Acid Oxidase Inhibitors
Sarah C Zimmermann, Rana Rais, Jesse Alt, et al.
Brain Research
|
January 31, 2016
Dose-dependent inhibition of GCPII to prevent and treat cognitive impairment in the EAE model of multiple sclerosis
Kristen R Hollinger, Jesse Alt, Alison M Riehm, et al.
Analytical Biochemistry
|
September 6, 2011
Development of a high-throughput method for the determination of pharmacological levels of plasma D-serine
Jesse Alt, Camilo Rojas, Krystyna Wozniak, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 26, 2024
The SWELL1 Channel Promotes Ischemic Brain Damage by Mediating Neuronal Swelling and Glutamate Toxicity
Jianan Chen, Junhua Yang, Jiachen Chu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 6, 2012
Reversible disulfide formation of the glutamate carboxypeptidase II inhibitor E2072 results in prolonged systemic exposures in vivo
Rana Rais, Randall Hoover, Krystyna Wozniak, et al.
Pharmaceutics
|
January 25, 2025
Pharmacokinetic Evaluation of Neutral Sphinghomyelinase2 (nSMase2) Inhibitor Prodrugs in Mice and Dogs
Arina Ranjit, Chae Bin Lee, Lukáš Tenora, et al.
Journal of Neurovirology
|
February 4, 2015
Neurological sequelae induced by alphavirus infection of the CNS are attenuated by treatment with the glutamine antagonist 6-diazo-5-oxo-l-norleucine
Michelle C Potter, Victoria K Baxter, Robert W Mathey, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 78) with videos related to
Sort By:
Page
of 8
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 26, 2013
Glutamate carboxypeptidase II is not an amyloid peptide-degrading enzyme
Jesse Alt, Marigo Stathis, Camilo Rojas, et al.
Analytical Biochemistry
|
January 14, 2015
Bioanalysis of 6-diazo-5-oxo-l-norleucine in plasma and brain by ultra-performance liquid chromatography mass spectrometry
Jesse Alt, Michelle C Potter, Camilo Rojas, et al.
Journal of Alzheimer'S Disease : JAD
|
March 19, 2019
The NAAG'ing Concerns of Modeling Human Alzheimer's Disease in Mice
Kristen R Hollinger, Jesse Alt, Rana Rais, et al.
ACS Medicinal Chemistry Letters
|
November 20, 2014
Structure-Metabolism Relationships in the Glucuronidation of d-Amino Acid Oxidase Inhibitors
Sarah C Zimmermann, Rana Rais, Jesse Alt, et al.
Brain Research
|
January 31, 2016
Dose-dependent inhibition of GCPII to prevent and treat cognitive impairment in the EAE model of multiple sclerosis
Kristen R Hollinger, Jesse Alt, Alison M Riehm, et al.
Analytical Biochemistry
|
September 6, 2011
Development of a high-throughput method for the determination of pharmacological levels of plasma D-serine
Jesse Alt, Camilo Rojas, Krystyna Wozniak, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 26, 2024
The SWELL1 Channel Promotes Ischemic Brain Damage by Mediating Neuronal Swelling and Glutamate Toxicity
Jianan Chen, Junhua Yang, Jiachen Chu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 6, 2012
Reversible disulfide formation of the glutamate carboxypeptidase II inhibitor E2072 results in prolonged systemic exposures in vivo
Rana Rais, Randall Hoover, Krystyna Wozniak, et al.
Pharmaceutics
|
January 25, 2025
Pharmacokinetic Evaluation of Neutral Sphinghomyelinase2 (nSMase2) Inhibitor Prodrugs in Mice and Dogs
Arina Ranjit, Chae Bin Lee, Lukáš Tenora, et al.
Journal of Neurovirology
|
February 4, 2015
Neurological sequelae induced by alphavirus infection of the CNS are attenuated by treatment with the glutamine antagonist 6-diazo-5-oxo-l-norleucine
Michelle C Potter, Victoria K Baxter, Robert W Mathey, et al.
Page
of 8